References
- Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–9
- Hara M, Koyanagi Y, Inoue T, Fukuyama T. Some physico-chemical characteristic of gamma “semiprotein” and antigenic component specific for human seminal plasma. Nippon Hoigaku Zasshi 1971;25:322–4
- Catalona WJ, Smith DS, Ratiff DL, et al. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;17:1156–61
- Diamandis EP, Yu H. New biological functions of prostate-specific antigen. J Clin Endocrinol Metab 1995;80:1515–17
- Diamandis EP, Yu H. Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 1997;24:275–82
- Radowicki S, Kunicki M, Badurska-Stankiewicz E. Prostate-specific antigen in the serum of women with benign breast disease. Eur J Obstet Gynecol Reprod Biol 2008;138:212–16
- Melegos DN, Yu H, Ashok M, et al. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997;82:777–80
- Wang MC, Valenzula LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17:159–63
- Yu H, Berkel H. Prostate-specific antigen (PSA) in women. J LA State Med Soc 1999;151:2019–23
- Burelli A, Cionini R, Rinaldi E, et al. Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome. J Endocrinol Invest 2006;29:308–12
- Mardanian F, Heidari N. Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome. J Res Med Sci 2011;16:999–1005
- Gullu S, Emral R, Asik M, et al. Diagnostic value of prostatic specific antigen in hirsute women. J Endocrinol Invest 2003;26:1198–202
- Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
- Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB. Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome. Endocrine 2009;35:123–9
- Vural B, Ozkan S, Bodur H. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? J Obstet Gynaecol Res 2007;33:166–73
- Bahceci M, Bilge M, Tuzcu A, et al. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide + desogestrel/ethinyl estradiol combination. J Endocrinol Invest 2004;27:353–6
- Kocak M, Tarcan A, Beydilli G, et al. Serum levels of prostate-specific antigen and androgens after nasal administration of gonadotropin releasing hormone-agonist in hirsute women. Gynecol Endocrinol 2004;18:179–85
- Obiezu CV, Scorilas A, Magklara A, et al. Prostate specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:1558–61
- Bili E, Dampala K, Iakovou I, et al. The combination of ovaria volume and outline has better diagnostics accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovaria syndrome. Eur J Obstet Gynecol Reprod Biol 2014;179:32–5